Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam

Malaria Journal

Volumn 5, Issue , 2006, Pages

  Kachur, S Patrick ^a,b   Black, Carolyn ^a,c   Abdulla, Salim ^a   Goodman, Catherine ^d  

^a IFAKARA HEALTH INSTITUTE   (Tanzania)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ;

ARTICLE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG COST; DRUG FORMULATION; DRUG LABELING; DRUG MARKETING; DRUG PACKAGING; PHARMACY; PRESCRIPTION; URBAN AREA;

ADMINISTRATION, ORAL; ANTIMALARIALS; ARTEMISININS; COMMERCE; DRUG COSTS; DRUG LABELING; DRUG PACKAGING; HUMANS; MALARIA; PHARMACIES; SUSPENSIONS; TABLETS; TANZANIA; URBAN HEALTH; WORLD HEALTH;

EID: 33646345837     PISSN: 14752875     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-5-25     Document Type: Article

References (26)

1. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, Kokwaro G, Ouma J, Hien TT, Molyneux ME, Taylor TE, Newbold CI, Ruebush TK 2nd, Danis M, Greenwood BM, Anderson RM, Olliaro P: Averting a malaria disaster. Lancet 1999, 353:1965-1967.
2. Bloland PB, Kachur SP, Williams HA: Trends in antimalarial drug deployment in sub-Saharan Africa. J Exp Biol 2003, 206:3761-3769.
3. Duffy PE, Mutabingwa TK: Drug combinations for malaria: time to ACT? Lancet 2004, 363:3-4.
4. Snow RW, Eckert E, Teklehaimanot A: Estimating the needs for artesunate-based combination therapy for malaria case-management in Africa. Trends Parasitol 2003, 19:363-369.
5. Mutabingwa TK: Artemisinin-based combination therapies (ACTs): Best hope for malaria treatment but inaccessible to the needy! Acta Trop 2005, 95:305-315.
6. United States Agency for International Development and Centers for Disease Control and Prevention: President's Malaria Initiative. Tanzania Rapid Assessment Report Dar-es-Salaam; 2005.
7. Kumaranayake L, Hongoro C, Lake S, Mujinja P, Mpembeni R: Coping with private health markets-regulatory (in)effectiveness in sub-Saharan Africa. In The new public/private mix in health: exploring the changing landscape Edited by: Soderlund N, Mendoza-Arana P, Goudge J. Geneva: Alliance for Health Policy and Systems Research; 2003.
8. Dondorp AM, Newton PN, Mayxay M, Van Damme W, Smithuis FM, Yeung S, Petit A, Lynam AJ, Johnson A, Hien TT, McGready R, Farrar JJ, Looareesuwan S, Day NP, Green MD, White NJ: Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials. Trop Med Int Health 2004, 9:1241-1246.
9. United Republic of Tanzania: Tanzania Food and Drugs Act 2003.
10. Ministry of Health. United Republic of Tanzania: Guidelines for Diagnosis and Treatment of Malaria. Dar-es-Salaam: National Malaria Control Programme Dar-es-Salaam: National Malaria Control Programme; 2001.
11. World Health Organization: Antimalarial Drug Combination Therapy: Report of a WHO Technical Consultation Geneva: World Health Organization; 2001.
12. Donnelly J: Resistance to malaria drug said to imperil millions. Boston Globe 2006:2.
13. United Republic of Tanzania: National Guidelines for Diagnosis and Treatment of Malaria (DRAFT) Dar-es-Salaam: National Malaria Control Programme; 2005.
14. Wang SJ, Lengeler C, Smith TA, Vounatsou P, Cisse G, Diallo DA, Akogbeto M, Mtasiwa D, Teklehaimanot A, Tanner M: Rapid urban malaria appraisal (RUMA) in sub-Saharan Africa. Malar J 2005, 4:40.
15. Obrist van Eeuwijk B: Struggling for Health in the City: An anthropological inquiry of health, vulnerability and resilience in Dar-es-Salaam, Tanzania Bern: Peter Lang, AG, European Academic Publishers; 2006.
16. World Health Organization: The use of antimalarial drugs. Report of an informal consultation, 13-17 November 2000 Geneva: World Health Organization; 2001.
17. Menard D, Matsika-Claquin MD, Djalle D, Yapou F, Manirakiza A, Dolmazon V, Sarda J, Talarmin A: Association of failures of seven-day courses of artesunate in a non-immune population in Bangui, Central African Republic with decreased sensitivity of Plasmodium falciparum. Am J Trop Med Hyg 2005, 73:616-621.
18. Institute of Medicine: Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance Washington: National Academies Press; 2004.
19. Senior K: Shortfall in front-line antimalarial drug likely in 2005. Lancet Infect Dis 2005, 5:75.
20. World Health Organization: Specifications for prepacking antimalarial medications. Report of a WHO technical consultation. Geneva World Health Organization; 2005.
21. Goodman C, Kachur SP, Abdulla S, Mwageni E, Nyoni J, Schellenberg JA, Mills A, Bloland P: Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities. Trop Med Int Health 2004, 9:655-663.
22. Kachur SP, Schulden J, Goodman CA, Kassala H, Elling BF, Khatib RA, Causer LM, Mkikima S, Abdulla S, Bloland P: Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania, 2004. Trop Med Int Health 2006, 11:441-451.
23. Ministry of Health: United Republic of Tanzania: National Malaria Medium-Term Strategic Plan, 2003-2007. Dar-es-Salaam: National Malaria Control Program; 2003.
24. Pagnoni F, Kengeya-Kayondo J, Ridley R, Were W, Nafo-Traore F, Namboze J, Sirima S: Artemisinin-based combination treatment in home-based management of malaria. Trop Med Int Health 2005, 10:621-622.
25. D'Alessandro U, Talisuna A, Boelaert M: Editorial: Should artemisinin-based combination treatment be used in the home-based management of malaria? Trop Med Int Health 2005, 10:1-2.
26. Gomes M, Wayling S, Pang L: Interventions to improve the use of antimalarials in south-east Asia: an overview. Bull World Health Organ 1998, 76(Suppl 1):9-19.